Toggle navigation
Goals &
Objectives
Distinguished
Faculty
Education &
Resources
Contact
Us
Toggle navigation
Goals & Objectives
Distinguished Faculty
Education & Resources▼
CME Programs
Find a Clinician
SpeakerReady
Polling Questions
Conference Calendar
Refer a Colleague
Literature
Resources
Contact
Polling Questions
< All Questions
According to the webcast:
With Risa Kagan, MD, FACOG, CCD, NCMP
Symptoms of vulvovaginal atrophy (VVA), now called genitourinary syndrome menopause (GSM):
A. Contribute to postmenopausal female sexual dysfunction (FSD) but not dyspareunia
B. Contribute to dyspareunia and FSD comorbidity
C. Do not contribute to either FSD or dyspareunia
D. Have not been evaluated in any study related to either dyspareunia or FSD
Your answers are confidential and will be used for educational purposes only.
Submit